Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Cardea Bio

Main (gene editing) focus:CRISPR-Chip technology

Genome editing tool: CRISPR-Chip-based diagnostics

Funding stage: Private

Location: San Diego, California, USA


Cardea Bio is a private, chip-based company focused on the development of its CRISPR-Chip technology as a diagnostics tool within genomes. The chip is based on deactivated Cas9 (dCas9), and the underlying principle is that it can be used to search a genome without cutting DNA. By doing this, Cardea can search for specific sites within genomes, and generate reads based on output from the chips' graphene transistor. Essentially, the company wants to create a technology wherein you can "Google a genome".


HashtagCardea Bio

Company: Cardea Bio
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine